{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:02:23Z","timestamp":1790877743771,"version":"4.1.0"},"reference-count":25,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,9,8]]},"DOI":"10.1136\/ejhpharm-2026-004967","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:24:36Z","timestamp":1790875476000},"page":"ejhpharm-2026-004967","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the clinical impact of carbapenem pre-authorisation on clinical outcomes in a setting with a high prevalence of extended-spectrum beta-lactamase producing organisms: a focus on the Middle East"],"prefix":"10.1136","author":[{"given":"Amna","family":"Nauman","sequence":"first","affiliation":[{"name":"Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-0590","authenticated-orcid":false,"given":"Wasim S","family":"El Nekidy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE"},{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"Abidi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"El Lababidi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100110200523000_ejhpharm-2026-004967v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02724-0"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.3","unstructured":"Drug-resistant infections: a threat to our economic future. 2027. Available: https:\/\/www.worldbank.org\/en\/topic\/health\/publication\/drug-resistant-infections-a-threat-to-our-economic-future"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.4","doi-asserted-by":"crossref","first-page":"160461","DOI":"10.1016\/j.scitotenv.2022.160461","article-title":"Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health","volume":"860","author":"Li","year":"2023","journal-title":"Science of The Total Environment"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.05.015"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.6","doi-asserted-by":"crossref","first-page":"100947","DOI":"10.1016\/j.lanmic.2024.07.010","article-title":"Antimicrobial resistance: a concise update","volume":"6","author":"Ho","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.7","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10070858","article-title":"Prescribers\u2019 Knowledge, Attitudes and Behaviors on Antibiotics, Antibiotic Use and Antibiotic Resistance in Jordan","volume":"10","author":"Karasneh","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.8","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.2905"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.9","unstructured":"World Health Organization . WHO updates list of drug-resistant bacteria most threatening to human health. 2024. Available: https:\/\/www.who.int\/news\/item\/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01110-18","article-title":"New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections","volume":"63","author":"Isler","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.11","article-title":"A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections","volume":"14","author":"Agyeman","year":"2022","journal-title":"Cureus"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254163"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.13","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050727"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.14","unstructured":"WHO . Global action plan on antimicrobial resistance. 2016. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241509763"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jac5.1087","article-title":"Implementation and outcomes of an advanced antimicrobial stewardship program at a quaternary care hospital in the United Arab Emirates","volume":"2","author":"El\u2010Lababidi","year":"2019","journal-title":"J Am Coll Clin Pharm"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.16","doi-asserted-by":"crossref","first-page":"106661","DOI":"10.1016\/j.ijantimicag.2022.106661","article-title":"Criteria Restricting Inappropriate Meropenem Empiricism (CRIME): a quasi-experimental carbapenem restriction pilot at a large academic medical centre","volume":"60","author":"Wells","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.17","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlac137","article-title":"Can\u2019t keep it SECRET: system evaluation of carbapenem restriction against empirical therapy","volume":"5","author":"Wells","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41710-4","article-title":"Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study","volume":"13","author":"Yoo","year":"2023","journal-title":"Sci Rep"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx273"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.21","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3408-2"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/00185787231160436","article-title":"Impact of Antimicrobial Stewardship Program Intervention Acceptance on Hospital Length of Stay","volume":"58","author":"Hurtado","year":"2023","journal-title":"Hosp Pharm"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.23","doi-asserted-by":"publisher","DOI":"10.1086\/375818"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae631.1925","article-title":"P-1762. Assessing the clinical impact of carbapenem pre-authorization in a high ESBL prevalence setting: a focus on the Middle East","volume":"12","author":"Nuaman","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026100110200523000_ejhpharm-2026-004967v1.25","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13080699","article-title":"Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy","volume":"13","author":"El Nekidy","year":"2024","journal-title":"Antibiotics (Basel)"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2026-004967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:24:39Z","timestamp":1790875479000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2026-004967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":25,"alternative-id":["10.1136\/ejhpharm-2026-004967"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2026-004967","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}